|
ADAR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.91779999950626E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.197700E-04 |
| Normal-vs-Stage2 |
3.038000E-03 |
| Normal-vs-Stage3 |
2.33640000002477E-06 |
| Normal-vs-Stage4 |
1.81105000000015E-05 |
| Stage1-vs-Stage2 |
4.065000E-01 |
| Stage1-vs-Stage3 |
6.208300E-02 |
| Stage1-vs-Stage4 |
1.267360E-01 |
| Stage2-vs-Stage3 |
6.264000E-01 |
| Stage2-vs-Stage4 |
7.095600E-01 |
| Stage3-vs-Stage4 |
8.863000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.82549999996995E-06 |
| Normal-vs-AfricanAmerican |
1.33950000003047E-06 |
| Normal-vs-Asian |
8.674400E-01 |
| Caucasian-vs-AfricanAmerican |
3.576200E-02 |
| Caucasian-vs-Asian |
2.890000E-01 |
| AfricanAmerican-vs-Asian |
6.604200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98579999999282E-07 |
| Normal-vs-Female |
5.643300E-04 |
| Male-vs-Female |
1.049970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.438300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.48470000000045E-06 |
| Normal-vs-Age(61-80Yrs) |
2.0683999999993E-05 |
| Normal-vs-Age(81-100Yrs) |
1.731620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.876000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.739200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.225200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.426400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.542200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.639600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.909400E-01 |
| Normal-vs-Grade 2 |
1.964410E-04 |
| Normal-vs-Grade 3 |
1.79249999998632E-06 |
| Normal-vs-Grade 4 |
1.50918999999305E-05 |
| Grade 1-vs-Grade 2 |
1.917010E-01 |
| Grade 1-vs-Grade 3 |
9.977700E-02 |
| Grade 1-vs-Grade 4 |
3.730200E-02 |
| Grade 2-vs-Grade 3 |
1.779560E-01 |
| Grade 2-vs-Grade 4 |
6.832300E-02 |
| Grade 3-vs-Grade 4 |
4.579200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.402200E-02 |
| Normal-vs-ccB subtype |
2.97980000008025E-07 |
| ccA subtype-vs-ccB subtype |
3.969900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.13570000000751E-05 |
| Normal-vs-N1 |
7.776600E-01 |
| N0-vs-N1 |
2.022800E-01 |
|
|
